Oncopeptides is based in Stockholm, Sweden. It has raised $130M in total funding.
Oncopeptides funding overview
Oncopeptides is based in Stockholm, Sweden. Oncopeptides has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Oncopeptides runs through 2021; nothing later has been disclosed. Investors on record include Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management. 3 distinct backers are named across the disclosed rounds.
Oncopeptides at a glance
Total raised
$130M
Latest round date
March 2021
Headquarters
Stockholm, Sweden
Notable investors
Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management
Frequently asked about Oncopeptides funding
How much has Oncopeptides raised?
Oncopeptides has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Oncopeptides?
Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management are named among the investors backing Oncopeptides.
What was the latest Oncopeptides funding round?
No round stage has been disclosed for Oncopeptides.
Where is Oncopeptides based?
Oncopeptides is based in Stockholm, Sweden.
When did Oncopeptides last raise?
The last disclosed Oncopeptides round closed in March 2021.
Oncopeptides totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Stockholm below to benchmark round size and investor mix.
